Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Flora-Q
- Development stage
- Unknown
- Lead developer
- Pharmaderm
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Flora-Q is an over-the-counter probiotic dietary supplement manufactured by PharmaDerm, a division of Fougera Pharmaceuticals Inc. [5, 6, 7]. It is a biologic product that contains a proprietary blend of live bacteria, including Lactobacillus acidophilus, Bifidobacterium, Lactobacillus paracasei, and Streptococcus thermophilus [5, 6]. Each capsule contains a minimum of 8 billion colony-forming units (CFU) at the time of manufacture, with a guaranteed potency of at least 4 billion CFU at expiration [5, 6, 7]. Flora-Q works by introducing beneficial bacteria to the gastrointestinal tract to help restore and maintain a healthy gut microbiome [4, 5]. It does not have a specific biological target in the traditional sense. It is used to support gastrointestinal health and has also been used for various conditions such as diarrhea (including antibiotic-associated and traveler's diarrhea), irritable bowel syndrome, and oral thrush. [1, 8]
- Brand names
- Flora-Q
Beyond the preview
Go deeper on Flora-Q.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Flora-Q.